Drug Shortage Report for BIO-QUETIAPINE
Report ID | 131509 |
Drug Identification Number | 02447223 |
Brand name | BIO-QUETIAPINE |
Common or Proper name | QUETIAPINE |
Company Name | BIOMED PHARMA |
Market Status | DORMANT |
Active Ingredient(s) | QUETIAPINE |
Strength(s) | 200MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-03-31 |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2021-01-13 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 9450 BOUL. LANGELIER MONTREAL, QUEBEC CANADA H1P 3H8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2021-01-13 | French | Compare |
v1 | 2021-01-13 | English | Compare |
Showing 1 to 2 of 2